Plasmid Transfection Reagent from Santa Cruz Biotechnology, Inc.

Product Specs
ItemPlasmid Transfection Reagent
CompanySanta Cruz Biotechnology, Inc.
Price $55.00Supplier Page View Company Product Page
Catalog Numbersc-108061
Quantity0.2 ml
TypeRNA Interference Products

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Thrombospondin 2 drives liver metastasis in skin cutaneous melanoma via regulation of angiogenesis and extracellular matrix remodelingMelanoma ResearchOctober 1, 2025Li-Ping Zhang, Zhen-Guo Zhang, Jian Guan, Li-Qun Li(sc-37031-SH; Santa Cruz Biotechnology, Dallas, Texas, USA) with corresponding plasmid transfection reagent (sc-108061) and transfection medium (sc-108062). A nontargeting control shRNA plasmid (shCtrl, sc-108060) was used

(2) Developmental pluripotency-associated 4 increases aggressiveness of pituitary neuroendocrine tumors by enhancing cell stemnessNeuro-OncologyJanuary 12, 2025Shaista Chaudhary, Ujjal Das, Shaima Jabbar, Omkaram Gangisetty, Bénédicte Rousseau, Simon Hanft, Dipak K Sarkarmicrogram of plasmid was mixed with Santa Cruz Biotechnology’s shRNA plasmid transfection reagent (sc-108061) at different ratios (1:1 to 1:6), and then transfection was done using shRNA plasmid transfection medium

(3) The selenoenzyme type I iodothyronine deiodinase: a new tumor suppressor in ovarian cancerMolecular OncologyMarch 1, 2024Adi Alfandari, Dotan Moskovich, Avivit Weisz, Aviva Katzav, Debora Kidron, Mario Beiner, Dana Josephy, Aula Asali, Yael Hants, Yael Yagur, et al.were performed following the manufacturer's instructions using shRNA plasmid transfection reagent (sc‐108061, Santa Cruz Technologies). GFP plasmid was used as a positive control (sc‐108083, Santa Cruz Technologies),

(4) Syndecan-4 Mediates the Cellular Entry of Adeno-Associated Virus 9International journal of molecular sciencesFebruary 5, 2023Hudák A, Roach M, Pusztai D, Pettkó-Szandtner A, Letoha A, Szilák L, Azzouz M, Letoha T.using a SDC4 shRNA plasmid (cat. no. sc-36588-SH), using shRNA plasmid transfection reagent (cat. no. sc-108061) according to the manufacturer’s protocol (Santa Cruz Biotechnology, Inc., Dallas, TX, USA). Control

(5) Design, synthesis, and biological evaluation of novel HSP27 inhibitors to sensitize lung cancer cells to clinically available anticancer agentsBioorganic chemistryJanuary 1, 2023Choi SK, Hwang SY, Jeon S, Yoo H, Lee J, Shin JH, Na Y, Kwon Y, Lee YS.

(6) Pyrolyzed deketene curcumin controls regulatory T cell generation and gastric cancer metabolism cooperate with 2-deoxy-d-glucoseFrontiers in immunologyJanuary 1, 2023MaruYama T, Miyazaki H, Lim YJ, Gu J, Ishikawa M, Yoshida T, Chen W, Owada Y, Shibata H.control shRNA (Santa Cruz Biotechnology) by using Plasmid Transfection Reagent (Santa Cruz Biotechnology, sc-108061). A fresh medium added 24 h after transfection and incubated for another 48h. Subsequently, the cells

(7) "Hyperglycemic Neurovasculature-On-A-Chip to Study the Effect of SIRT1-Targeted Therapy for the Type 3 Diabetes ""Alzheimer's Disease"""Advanced science (Weinheim, Baden-Wurttemberg, Germany)December 1, 2022Jang M, Choi N, Kim HN.hBMECs following the manufacturer's protocol. shRNA (1 µg) and shRNA Plasmid Transfection Reagent (sc‐108061, Santa Cruz, United States) were diluted in plasmid transfection medium (sc‐108062, Santa Cruz, United

(8) Monocarboxylate transporter 1 is a novel target for breast cancer stem like-cell inhibition by diallyl trisulfideMolecular carcinogenesisAugust 1, 2022Kim SH, Singh SV.

(9) Inhibition of ClC-5 suppresses proliferation and induces apoptosis in cholangiocarcinoma cells through the Wnt/β-catenin signaling pathwayBMB reportsJune 1, 2022Shi Z, Zhou L, Zhou Y, Jia X, Yu X, An X, Han Y.plasmids were transfected into QBC939 and SUN-869 cells by using shRNA plasmid transfection reagent (#sc-108061, Santa Cruz), respectively. Briefly, in a 6-well plate, grew cells to a 80% confluency in normal growth

(10) Berberine remodels adipose tissue to attenuate metabolic disorders by activating sirtuin 3Acta pharmacologica SinicaMay 1, 2022Li D, Yang C, Zhu JZ, Lopez E, Zhang T, Tong Q, Peng C, Lin LG.

(11) Transcriptomic Analysis of Fumarate Compounds Identifies Unique Effects of Isosorbide Di-(Methyl Fumarate) on NRF2, NF-kappaB and IRF1 Pathway GenesPharmaceuticals (Basel, Switzerland)April 11, 2022Swindell WR, Bojanowski K, Chaudhuri RK.

(12) Targeting extracellular matrix glycation to attenuate fibroblast activationActa biomaterialiaMarch 15, 2022Jang M, Oh SW, Lee Y, Kim JY, Ji ES, Kim P.

(13) Silencing of α-N-acetylgalactosaminidase in the gastric cancer cells amplified cell death and attenuated migration, while the multidrug resistance remained unchangedCell biology internationalFebruary 1, 2022Jafari M, Rahimi N, Jami MS, Hashemzadeh Chaleshtori M, Elahian F, Mirzaei SA.

(14) Dexamethasone Sensitizes Acute Monocytic Leukemia Cells to Ara-C by Upregulating FKBP51Frontiers in oncologyJanuary 1, 2022Sun H, Liu X, Wang L, Cui B, Mu W, Xia Y, Liu S, Liu X, Jiao Y, Zhao Y.States). The FKBP51 shRNA plasmid (h) (sc-35380-sh), scramble shRNA (sc-108060) and transfection reagent (sc-108061) as well as the primary antibodies against FKBP51 (sc-271547) and GAPDH (sc-47724) were purchased from

(15) Deoxycholic acid delays the wound healing of colonic epithelial cells via transmembrane G-protein-coupled receptor 5Journal of gastroenterology and hepatologyJanuary 1, 2022Azuma Y, Uchiyama K, Sugaya T, Yasuda T, Hashimoto H, Kajiwara-Kubota M, Sugino S, Kitae H, Torii T, Mizushima K, et al.

(16) Distinct cholangiocarcinoma cell migration in 2D monolayer and 3D spheroid culture based on galectin-3 expression and localizationFrontiers in oncologyJanuary 1, 2022Sukphokkit S, Kiatwuthinon P, Kumkate S, Janvilisri T.

(17) Honokiol attenuates lipotoxicity in hepatocytes via activating SIRT3-AMPK mediated lipophagyChinese medicineNovember 10, 2021Liu J, Zhang T, Zhu J, Ruan S, Li R, Guo B, Lin L.SIRT3 (mouse, sc-61556), scrambled shRNA (mouse, sc-1080600), and shRNA transfection reagent (mouse, sc-108061) were provided by Santa Cruz Biotechnology (Santa Cruz, CA, USA). Cell culture and treatments AML12

(18) Interaction of Fibromodulin and Myostatin to Regulate Skeletal Muscle Aging: An Opposite Regulation in Muscle Aging, Diabetes, and Intracellular Lipid AccumulationCellsAugust 13, 2021Lee EJ, Ahmad SS, Lim JH, Ahmad K, Shaikh S, Lee YS, Park SJ, Jin JO, Lee YH, Choi I.

(19) Helios serves as a suppression marker to reduce regulatory T cell function in pancreatic cancer patientsImmunologic researchJune 1, 2021Liu MF, Jin C, Wu T, Chen EH, Lu M, Qin HL.

(20) Drug-Like Small Molecule HSP27 Functional Inhibitor Sensitizes Lung Cancer Cells to Gefitinib or Cisplatin by Inducing Altered Cross-Linked Hsp27 DimersPharmaceuticsApril 28, 2021Yoo H, Choi SK, Lee J, Park SH, Park YN, Hwang SY, Shin JH, Na Y, Kwon Y, Lee HJ, et al.for HSP27 (puromycin resistance gene). The HSP27 shRNA Plasmid (sc-2935-SH) and Transfection Reagent (sc-108061) for shRNA plasmid were ordered from Santa Cruz Biotechnology. To generate shControl and shHSP27 cells,

Be the First to Write a Review!